COVID-19 Articles
Coronavirus Corruption: Bad Incentives and Politics as UsualBy Raymond March on May, 28, 2020Blog | The Beacon, Independent Institute |
Keep Government Out of Developing a COVID-19 VaccineBy Raymond March on May 27, 2020Blog | The Beacon, Independent Institute |
Examining the COVID-19 Data: Basic Principles for Interpreting Time Series DataBy James Caton on May 26, 2020Blog | Center for the Study of Public Choice and Private Enterprise |
Visualizations are Powerful, But Often MisleadingBy James Caton on May 23, 2020Blog | American Institute for Economic Research |
A Forecast of the Effect of COVID-19 on North Dakota's EconomyWith Jeremy Jackson on May 22, 2020Webinar | Economic Outlook |
More Executive Orders Will Not Fix HealthcareBy Raymond March on May 21, 2020Blog | The Beacon, Independent Institute |
Most Places are Not New York: A Look Through the COVID-19 DataBy James Caton on May 14, 2020Blog | American Institute for Economic Research |
Pandemic Protection and Economic Growth are Complements, Not SubstitutesBy Raymond March on May 6, 2020Column | Spotlight on Economics |
Economic Outlook: A forecast of the effect of COVID-19 on North DakotaReleased May 2020Report | North Dakota Forecast Model |
Beware a Second-Wave Attack on LibertyBy James Caton on May 1, 2020Blog | American Institute for Economic Research |
Private Enterprise Continues to Flatten the CurveBy Raymond March on April 28, 2020Blog | The Beacon, Independent Institute |
Raymond J. March Reviews the FDA's Response to the PandemicWith Raymond March on April 27, 2020Podcast | The Liam McCollum Show, Ep. 17 |
Can Deregulation Help Fight Pandemics Better?: Health Policy Lessons from COVID-19With Raymond March on April 18, 2020Panel | Policy in Pandemic virtual conference |
Economic Prosperity or Pandemic Protection: Why Not Both?By Raymond March on April 15, 2020Blog | The Beacon, Independent Institute |
Rely on Private Enterprise to "Flatten the Curve"By Raymond March on April 10, 2020Video Interview | Independent Institute |
Cut Regulations and Get COVID-19 Drugs to PatientsBy Raymond March on April 8, 2020Blog | The Beacon, Independent Institute |
Look to local efforts to flatten the curveBy Raymond March on April 2, 2020Op-Ed | The Forum of Fargo-Moorhead |
Make licensure reciprocity permanentBy Jeremy Jackson on March 30, 2020Op-Ed | The Bismarck Tribune |
Free the Entrepreneurs to Deal with the COVID-19 CrisisBy James Caton on March 28, 2020Blog | American Institute for Economic Research |
We need civil discourse, even in an emergencyBy Ryan Yonk on March 26, 2020Op-Ed | The Forum of Fargo-Moorhead |
Trust private enterprise to flatten the curveBy Raymond March on March 26, 2020Op-Ed | The Hill |
Right-to-Try Laws Can Help Drugmakers Combat the CoronavirusBy Raymond March on April 1, 2020Blog | The Beacon, Independent Institute |
To Battle Covid-19, Cut Regulation!By Raymond March on March 25, 2020Blog | The Beacon, Independent Institute |
Favor Local Action to Combat the CoronavirusBy Raymond March on March 19, 2020Blog | The Beacon, Independent Institute |
FDA Acknowledges Coronavirus Causing More Drug ShortagesBy Raymond March on March 6, 2020Blog | The Beacon, Independent Institute |
The Coronavirus Reveals the Limits of Monetary PolicyBy James Caton on March 2, 2020Blog | Sound Money Project, American Institute for Economic Research |